Barclays Starts Cabot Corp. (CBT) at Overweight

Barclays analyst Michael Leithead initiates coverage on Cabot Corp. (NYSE: CBT) with a Overweight rating and a price target of $76.00.

The analyst expects the company's earnings growth to remain elevated for the coming years on the back of benefits from cyclical tailwinds, incremental earnings from new capacity additions and diminishing headwinds from a poor acquisition and unmet lofty expectations set by the previous management team.

For an analyst ratings summary and ratings history on Cabot Corp. click here. For more ratings news on Cabot Corp. click here.

Shares of Cabot Corp. closed at $63.76 yesterday.

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Diana Shipping withdraws bid to acquire Genco Shipping